002022.SZ · 科华生物
China A-shares · RS rating 92 · As of 2026-10-14
| Price | 5.99 CNY |
|---|---|
| 1-day change | -2.1% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 87 / 93 / 62 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 41 / 28 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +12.0% |
| Distance from 52-week high | +15.5% |
| Market cap (USD) | $492.7M |